A recent study highlighted the potential synergistic hepatoprotective role of c-Met and NRF2 in NASH by investigating the consequences of combined c-Met/Keap1 gene deletion in hepatocytes in rodent models of steatohepatitis. Here, KEAP1 is linked to metabolic dysfunction-associated steatohepatitis.